Activities of Simona BALDASSARRE related to 2019/2816(RSP)
Institutional motions (1)
MOTION FOR A RESOLUTION on a strategic approach to pharmaceuticals in the environment
Amendments (1)
Amendment 161 #
Paragraph 16
16. Considers that the environmental impacts of pharmaceuticals could be included into the benefit-risk assessment of human medicines, as is already the case for veterinary medicine by drawing up multiple comparative environmental risk assessment tables without compromising access to safe and effective pharmacological treatments;